1 – 10 of 50
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
APOE4 impact on soluble and insoluble tau pathology is mostly influenced by amyloid-beta
- Contribution to journal › Article
-
Mark
Precuneus Activity during Retrieval Is Positively Associated with Amyloid Burden in Cognitively Normal Older APOE4 Carriers
- Contribution to journal › Article
-
Mark
Predictive Value of Plasma Biomarkers in Tau-PET Transitions
- Contribution to journal › Article
-
Mark
Shared and disease-specific pathways in frontotemporal dementia and Alzheimer’s and Parkinson’s diseases
- Contribution to journal › Article
-
Mark
The PREVENT-AD cohort : Accelerating Alzheimer's disease research and treatment in Canada and beyond
- Contribution to journal › Article
-
Mark
Machine learning prediction of tau-PET in Alzheimer's disease using plasma, MRI, and clinical data
- Contribution to journal › Article
-
Mark
Tau, atrophy, and domain-specific cognitive impairment in typical Alzheimer's disease
- Contribution to journal › Article
-
Mark
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease : A Meta-Analysis
- Contribution to journal › Article
-
Mark
Differential effects of aging, Alzheimer's pathology, and APOE4 on longitudinal functional connectivity and episodic memory in older adults
- Contribution to journal › Article
-
Mark
A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker tests
- Contribution to journal › Article
